Vor Biopharma Inc. (NASDAQ: VOR) is a Healthcare company (Biotechnology) with a market capitalization of $985M. The Maz Rating grades it against the other companies in its sector.
Vor Biopharma Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $18.18, Vor Biopharma Inc. trades at 0.1x trailing earnings, with an EV/EBITDA of 0.7. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -830.4%, return on invested capital of -38.5% and a free cash flow yield of -12.2%. On the balance sheet: a debt-to-equity ratio of -0.02 and a current ratio of 13.50. Over the past 52 weeks the share price ranged from $6.50 to $26.00, with a beta of 1.83.
Vor Biopharma Inc. does not currently pay a dividend.
13 Wall Street analyst ratings cover the stock: 10 Buy and 3 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.